Sequencing the human genome

Hospital Practice
F S Collins

Abstract

By 2005, or sooner, the three billion code letters of a representative human genome will be known, along with the locations of all of its genes. Even today, however, the work is greatly accelerating identification of disease-related genes. One outcome will be tests for genetic components of risk in the majority of common illnesses. In the longer run, genetic discoveries will surely lead to new treatments.

References

Dec 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·E C Uberbacher, R J Mural
Nov 21, 1995·Proceedings of the National Academy of Sciences of the United States of America·M S Guyer, F S Collins
Sep 7, 1995·The New England Journal of Medicine·M S Boguski
Apr 1, 1995·Nature Genetics·F S Collins
Jan 18, 1996·The New England Journal of Medicine·F S Collins
Dec 1, 1995·Trends in Genetics : TIG·H J Cordell, J A Todd
Oct 25, 1996·Science·E S Lander

❮ Previous
Next ❯

Citations

Oct 23, 1998·Journal of Gerontological Nursing·D L Schutte
Mar 10, 2016·Harvard Review of Psychiatry·Joseph T CoyleGlenn T Konopaske
Jan 1, 2002·Occupational Therapy in Health Care·Jennie Q Lou
Oct 23, 1997·Arthritis and Rheumatism·F C Arnett, R Chakraborty
Dec 18, 1998·AACN Clinical Issues·C Kenner
Mar 24, 2004·Current Opinion in Chemical Biology·Joseph Pearlberg, Joshua LaBaer

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.